AI in Clinical Trials Market: Size, Trends, and Growth Forecast to 2033
The AI in Clinical Trials industry is rapidly evolving as artificial intelligence technologies become integral in accelerating drug development and optimizing trial processes. This market is witnessing significant innovation driven by enhanced data analytics, automation, and predictive modeling, which are transforming clinical trial methodologies in 2024 and 2025. The AI in Clinical Trials market size and revenue are set to reflect this growing adoption across pharmaceutical and biotechnology sectors globally.
Market Size and Overview
The Global AI in Clinical Trials Market is estimated to be valued at USD 1.77 Billion in 2025 and is expected to reach USD 5.12 Billion by 2032, growing at a compound annual growth rate (CAGR) of 16.4% from 2025 to 2032.
This market growth is driven by increased adoption of AI-powered solutions that reduce trial timelines, enhance patient recruitment, and improve data quality. The market report highlights that AI integration within clinical trial protocols has significantly expanded AI in Clinical Trials Market Scope and opportunities, fostering business growth across key geographies.
AI in Clinical Trials Market-https://www.coherentmi.com/ind....ustry-reports/ai-in-
